T Cell News and Research

Latest T Cell News and Research

Promising approach to stem cell therapy for treating Parkinson's disease

A major factor underlying Parkinson's Disease pathology is the loss of dopamine neurons in the substantia nigra, and thus current therapies often aim to restore dopamine signaling. However, these treatments are not curative.

24 Jul 2018

Study reveals how giant neurons in the brain may play huge role in generalized arousal

There is no shortage of wonders that our central nervous system produces--from thought and language to movement to the five senses.

23 Jul 2018

Study finds new enzyme that lays foundations for allergic immune response

While in search of the causes of allergies and asthma, a chance discovery has yielded new clues: researchers led by Dr Marcus Peters have ascertained that the enzyme guanylate cyclase in cells lays the foundations for the type of immune response.

23 Jul 2018

Mysterious molecule Yin Yang may fuel tumor growth in breast cancer

Scientists have unveiled clues about a mysterious molecule called Yin Yang1 - and revealed it may fuel tumor growth in breast cancer.

23 Jul 2018

Imaging study shows how junk DNA activates genes

Researchers at Princeton University have used video imaging to capture the process by which junk DNA activates genes.

23 Jul 2018

Discovery about how malaria moves could lead to new therapies

Researchers have made an important discovery about how Plasmodium falciparum (the parasite that causes malaria) is able to evade capture by the immune system.

23 Jul 2018

New project explores health effects of dangerous chemicals

The EDC-MIXRISK project is exploring the health effects of a group of man-made substances that have been shown to disrupt the body’s endocrine system, the collection of hormone-producing glands that regulate growth and development, metabolism, reproduction and even mood and sleep patterns.

23 Jul 2018

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.

23 Jul 2018

Using tendon transfer surgery to restore key functions in spinal cord injury patient

After suffering a severe cervical spinal cord injury from a bad fall at work, Scott McConnell had little function remaining in his hands and arms.

20 Jul 2018

UC San Diego researchers awarded two grants for investigating stem cell-based therapies

The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.

20 Jul 2018

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

The U.S. Food and Drug Administration today approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation.

20 Jul 2018

Study looks into mechanisms that control sleep and wakefulness

Sleep is an autonomic process and is not always under our direct, voluntary control. Awake or asleep, we are basically under the regulation of two biological processes: sleep homeostasis, commonly known as 'sleep pressure', and the circadian rhythm, otherwise known as the 'body clock'.

20 Jul 2018

New research project investigates alternative treatments for eye infections

Fight for Sight has announced funding for an innovative research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection.

20 Jul 2018

Karius Test accurately detects invasive fungal infections, shows study

Karius, a life sciences company transforming infectious disease diagnostics with genomics and data through the innovative use of next-generation sequencing to analyze microbial cell-free DNA, announced today the positive results of a clinical study using blood samples from patients with confirmed invasive fungal infections.

20 Jul 2018

AVITA Medical expands management team to support launch of RECELL device to treat burns

AVITA Medical today announced that it expanded its management team in the commercial, legal and medical affairs functions to support the planned U.S. launch of the RECELL® Autologous Cell Harvesting Device in the treatment of burns

20 Jul 2018

Researchers uncover cause for progression of prostate cancer to incurable stage

Researchers at the University of Oulu in Finland have discovered novel genes and mechanisms that can explain how a genomic variant in a single nucleotide polymorphism rs11672691 influences prostate cancer aggressiveness.

20 Jul 2018

Researchers present evidence of phage cooperation when attacking CRISPR-containing bacteria

CRISPR, or clustered regularly interspaced short palindromic repeats, are an essential part of bacterial immunity designed to defend against foreign DNA. In bacteria, CRISPR acts just like it does in human cells as a pair of scissors, in their case with the goal of cutting strands of infecting DNA.

20 Jul 2018

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

A drug currently in clinical trials for treating symptoms of Parkinson's disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

20 Jul 2018

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

20 Jul 2018

Whole-brain LIPUS therapy improves cognitive dysfunction in mice simulating dementia, Alzheimer's

Ultrasound waves applied to the whole brain improve cognitive dysfunction in mice with conditions simulating vascular dementia and Alzheimer's disease.

20 Jul 2018

T Cell News and Research

Latest T Cell News and Research

Promising approach to stem cell therapy for treating Parkinson's disease

Study reveals how giant neurons in the brain may play huge role in generalized arousal

Study finds new enzyme that lays foundations for allergic immune response

Mysterious molecule Yin Yang may fuel tumor growth in breast cancer

Imaging study shows how junk DNA activates genes

Discovery about how malaria moves could lead to new therapies

New project explores health effects of dangerous chemicals

Pfizer announces FDA approval of biosimilar to Neupogen

Using tendon transfer surgery to restore key functions in spinal cord injury patient

UC San Diego researchers awarded two grants for investigating stem cell-based therapies

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

Study looks into mechanisms that control sleep and wakefulness

New research project investigates alternative treatments for eye infections

Karius Test accurately detects invasive fungal infections, shows study

AVITA Medical expands management team to support launch of RECELL device to treat burns

Researchers uncover cause for progression of prostate cancer to incurable stage

Researchers present evidence of phage cooperation when attacking CRISPR-containing bacteria

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Whole-brain LIPUS therapy improves cognitive dysfunction in mice simulating dementia, Alzheimer's

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in